Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
PMS1	0	broad.mit.edu	37	2	190742066	190742066	+	Missense_Mutation	SNP	C	C	G			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr2:190742066C>G	ENST00000441310.2	+	13	2936	c.2703C>G	c.(2701-2703)atC>atG	p.I901M	PMS1_ENST00000447232.2_Missense_Mutation_p.I739M|PMS1_ENST00000409823.3_Missense_Mutation_p.I862M|PMS1_ENST00000418224.3_Missense_Mutation_p.I725M|PMS1_ENST00000432292.3_Missense_Mutation_p.I725M	NM_000534.4	NP_000525.1	P54277	PMS1_HUMAN	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)	901		NA			mismatch repair|reciprocal meiotic recombination	MutLalpha complex	ATP binding|ATPase activity|mismatched DNA binding	p.I901M(1)	NA	breast(3)|central_nervous_system(1)|endometrium(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(3)|large_intestine(5)|lung(16)|ovary(2)|upper_aerodigestive_tract(1)|urinary_tract(1)	36			OV - Ovarian serous cystadenocarcinoma(117;0.0013)|Epithelial(96;0.0263)|all cancers(119;0.0751)			AAGACATTATCTACAGAATGA	0.378		NA	"""Mis, N"""	NA		"""colorectal, endometrial, ovarian"""	NA	Direct reversal of damage;Mismatch excision repair (MMR)			NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		yes	Rec		Hereditary non-polyposis colorectal cancer	2	2q31-q33	5378	PMS1 postmeiotic segregation increased 1 (S. cerevisiae)	NA	E	1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		127	120	122	NA	NA	NA	NA	2	NA	NA		NA						NA			NA				190742066		2203	4300	6503	SO:0001583	missense			ENSG00000064933	HGNC:9121		Approved	uc002urh.4	NA	D3DPI1	ENST00000441310.2	37	CCDS2302.1	.	.	.	.	.	.	.	.	.	.	C	10.32	1.316285	0.23908	.	.	ENSG00000064933	ENST00000441310;ENST00000418224;ENST00000409823;ENST00000447232;ENST00000432292;ENST00000409593	D;D;D;D;D;D	0.97279	-2.6;-2.34;-2.77;-3.12;-2.34;-4.32	5.76	0.514	0.17007	.	0.253669	0.46442	N	0.000291	D	0.91389	0.7283	N	0.25380	0.74	0.23325	N	0.997901	B;P;B;B;B	0.36753	0.009;0.568;0.201;0.077;0.058	B;B;B;B;B	0.38378	0.003;0.272;0.051;0.034;0.035	D	0.85375	0.1116	10	0.48119	T	0.1	-2.2883	2.6424	0.04975	0.2102:0.3483:0.3021:0.1394	.	217;524;862;739;901	Q5FBZ4;Q5FBZ6;Q5FBZ3;Q5FBZ8;P54277	.;.;.;.;PMS1_HUMAN	M	901;725;862;739;725;524	ENSP00000406490:I901M;ENSP00000404492:I725M;ENSP00000387125:I862M;ENSP00000401064:I739M;ENSP00000398378:I725M;ENSP00000387169:I524M	ENSP00000387169:I524M	I	+	3	3	PMS1	190450311	0.071000	0.21146	0.902000	0.35471	0.989000	0.77384	0.092000	0.15066	0.424000	0.26061	-0.150000	0.13652	ATC	PMS1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000255918.2	7.094899	KEEP		+	28.597691	0.093023	12	117	---	---	---	---	1	0.5795126	3	18	0	108	12	125	0	108	2	0	0	0	0	0	0	12	125	0	108	2	TP
Unknown	0	broad.mit.edu	37	4	106407236	106407236	+	IGR	SNP	A	A	G			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr4:106407236A>G			NA	NA				PPA2 (11998 upstream) : AC004066.3 (54110 downstream)						NA		NA							NA		NA						AAGGCTAAATAAATATTATCC	0.458		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		0			NA	NA	NA	NA	NA				NA		NA	NA	NA	NA	NA	NA	NA		NA	NA		NA						NA			NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			-1.17776	KEEP			12.602276	0.069444	5	67	---	---	---	---	1	0.4004518	13	1	1	108	7	72	1	108	2	0	0	0	0	0	0	7	72	1	108	2	TP
Unknown	0	broad.mit.edu	37	4	106407250	106407250	+	IGR	SNP	C	C	A			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr4:106407250C>A			NA	NA				PPA2 (12012 upstream) : AC004066.3 (54096 downstream)						NA		NA							NA		NA						ATTATCCCTACTACCTGCCAC	0.448		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		0			NA	NA	NA	NA	NA				NA		NA	NA	NA	NA	NA	NA	NA		NA	NA		NA						NA			NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			-0.680898	KEEP			11.764855	0.074627	5	62	---	---	---	---	1	0.3546214	12	0	1	99	7	68	1	99	2	0	0	0	0	0	0	7	68	1	99	2	TP
CDKAL1	54901	broad.mit.edu	37	6	20758841	20758841	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr6:20758841C>T	ENST00000274695.4	+	7	651	c.484C>T	c.(484-486)Cgt>Tgt	p.R162C	CDKAL1_ENST00000378610.1_Missense_Mutation_p.R162C|RP3-348I23.2_ENST00000421167.1_RNA|CDKAL1_ENST00000378624.4_Missense_Mutation_p.R92C	NM_017774.3	NP_060244.2	Q5VV42	CDKAL_HUMAN	CDK5 regulatory subunit associated protein 1-like 1	162	MTTase N-terminal.	NA			RNA modification	integral to membrane	4 iron, 4 sulfur cluster binding|metal ion binding|transferase activity	p.R162C(1)	NA	breast(1)|endometrium(4)|kidney(2)|large_intestine(5)|lung(14)|ovary(2)|stomach(1)	29	all_epithelial(95;0.0708)|Breast(50;0.131)|Ovarian(93;0.227)		OV - Ovarian serous cystadenocarcinoma(7;0.0241)|all cancers(50;0.123)|Epithelial(50;0.248)			GCAGATAGATCGTGTGGTAGA	0.328		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		114	122	119	NA	NA	NA	NA	6	NA	NA		NA						NA			NA				20758841		2203	4299	6502	SO:0001583	missense			ENSG00000145996	HGNC:21050	NM_017774	Approved	uc003ndd.2	NA	A8K6S0|Q6P385|Q6ZR27|Q9NXB3	ENST00000274695.4	37	CCDS4546.1	.	.	.	.	.	.	.	.	.	.	C	19.00	3.742088	0.69418	.	.	ENSG00000145996	ENST00000274695;ENST00000378624;ENST00000378610	T;T;T	0.51574	0.7;0.73;0.7	5.62	5.62	0.85841	Methylthiotransferase, N-terminal (1);	0.000000	0.85682	D	0.000000	T	0.63022	0.2476	M	0.89904	3.07	0.80722	D	1	D;P	0.56035	0.974;0.937	P;P	0.55112	0.769;0.534	T	0.71520	-0.4568	10	0.72032	D	0.01	-12.6183	15.1474	0.72667	0.0:1.0:0.0:0.0	.	92;162	Q5VV42-2;Q5VV42	.;CDKAL_HUMAN	C	162;92;162	ENSP00000274695:R162C;ENSP00000367889:R92C;ENSP00000367873:R162C	ENSP00000274695:R162C	R	+	1	0	CDKAL1	20866820	1.000000	0.71417	1.000000	0.80357	0.784000	0.44337	4.196000	0.58407	2.650000	0.89964	0.591000	0.81541	CGT	CDKAL1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		3.569247	KEEP		+	15.52862	0.09589	7	66	---	---	---	---	1	0.6986219	3	18	0	108	9	73	0	108	2	0	0	0	0	0	0	9	73	0	108	2	TP
PHF1	5252	broad.mit.edu	37	6	33380553	33380553	+	Missense_Mutation	SNP	G	G	A			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr6:33380553G>A	ENST00000374516.3	+	4	591	c.320G>A	c.(319-321)tGt>tAt	p.C107Y	PHF1_ENST00000374512.3_Missense_Mutation_p.C107Y|PHF1_ENST00000459809.1_3'UTR	NM_024165.2	NP_077084.1	O43189	PHF1_HUMAN	PHD finger protein 1	107		NA			chromatin modification	nucleus	nucleic acid binding|sequence-specific DNA binding transcription factor activity|zinc ion binding	p.C107Y(1)	NA	endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|kidney(4)|large_intestine(1)|lung(5)|ovary(2)|prostate(2)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)	19		Ovarian(999;0.0443)				CTGGTCAGCTGTGAGAAGTGT	0.577		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		140	126	131	NA	NA	NA	NA	6	NA	NA		NA						NA			NA				33380553		2203	4300	6503	SO:0001583	missense			ENSG00000112511	HGNC:8919		Approved	uc003oeh.3	NA	B1AZX2|B1AZX3|O60929|Q5SU07|Q5SU08|Q96KM7	ENST00000374516.3	37	CCDS4777.1	.	.	.	.	.	.	.	.	.	.	G	20.9	4.060604	0.76074	.	.	ENSG00000112511	ENST00000427004;ENST00000428274;ENST00000374512;ENST00000374516	D;D;D;D	0.99947	-8.64;-8.64;-8.64;-8.64	5.03	5.03	0.67393	Zinc finger, PHD-finger (2);Zinc finger, RING/FYVE/PHD-type (1);Zinc finger, PHD-type, conserved site (1);Zinc finger, PHD-type (1);Zinc finger, FYVE/PHD-type (1);	0.000000	0.85682	D	0.000000	D	0.99953	0.9980	M	0.89840	3.065	0.58432	D	0.999999	D;D	0.89917	1.0;0.997	D;D	0.97110	1.0;0.995	D	0.95462	0.8544	10	0.87932	D	0	-38.3669	15.8843	0.79232	0.0:0.0:1.0:0.0	.	107;107	O43189-2;O43189	.;PHF1_HUMAN	Y	107	ENSP00000410494:C107Y;ENSP00000392697:C107Y;ENSP00000363636:C107Y;ENSP00000363640:C107Y	ENSP00000363636:C107Y	C	+	2	0	PHF1	33488531	1.000000	0.71417	1.000000	0.80357	0.999000	0.98932	7.495000	0.81514	2.614000	0.88457	0.655000	0.94253	TGT	PHF1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076175.3	-7.937835	KEEP		+	13.836958	0.063636	7	103	---	---	---	---	1	0.9928671	30	95	0	104	8	108	0	104	2	0	0	0	0	0	0	8	108	0	104	2	TP
TMEM106B	54664	broad.mit.edu	37	7	12270022	12270022	+	Missense_Mutation	SNP	A	A	G			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr7:12270022A>G	ENST00000396667.2	+	7	912	c.590A>G	c.(589-591)tAc>tGc	p.Y197C	TMEM106B_ENST00000396668.3_Missense_Mutation_p.Y197C	NM_018374.3	NP_060844.2	Q9NUM4	T106B_HUMAN	transmembrane protein 106B	197		NA		Y -> N (in Ref. 2; BAD96983).		integral to membrane		p.Y197C(1)	NA	NS(1)|endometrium(8)|large_intestine(2)|lung(7)	18				UCEC - Uterine corpus endometrioid carcinoma (126;0.185)		CAGATTGATTACACAGTACCT	0.264		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		123	129	127	NA	NA	NA	NA	7	NA	NA		NA						NA			NA				12270022		2202	4298	6500	SO:0001583	missense			ENSG00000106460	HGNC:22407	NM_018374	Approved	uc003ssh.3	NA	A4D108|Q53FL9|Q8N4L0	ENST00000396667.2	37	CCDS5358.1	.	.	.	.	.	.	.	.	.	.	A	21.7	4.192688	0.78902	.	.	ENSG00000106460	ENST00000396668;ENST00000396667	T;T	0.33654	1.4;1.4	5.87	5.87	0.94306	.	0.000000	0.85682	D	0.000000	T	0.61825	0.2378	M	0.80183	2.485	0.80722	D	1	D	0.76494	0.999	D	0.66497	0.944	T	0.66893	-0.5808	10	0.72032	D	0.01	.	15.9373	0.79720	1.0:0.0:0.0:0.0	.	197	Q9NUM4	T106B_HUMAN	C	197	ENSP00000379902:Y197C;ENSP00000379901:Y197C	ENSP00000379901:Y197C	Y	+	2	0	TMEM106B	12236547	1.000000	0.71417	0.999000	0.59377	0.929000	0.56500	8.491000	0.90468	2.230000	0.72887	0.533000	0.62120	TAC	TMEM106B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000246870.2	-10.552052	KEEP		+	13.659125	0.065574	8	114	---	---	---	---	1	0.9999179	100	266	0	136	8	138	0	136	2	0	0	0	0	0	0	8	138	0	136	2	TP
EGFR	1956	broad.mit.edu	37	7	55210075	55210075	+	Missense_Mutation	SNP	T	T	G			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr7:55210075T>G	ENST00000275493.2	+	2	362	c.185T>G	c.(184-186)cTt>cGt	p.L62R	EGFR_ENST00000342916.3_Missense_Mutation_p.L62R|EGFR_ENST00000344576.2_Missense_Mutation_p.L62R|EGFR_ENST00000442591.1_Missense_Mutation_p.L62R|EGFR_ENST00000455089.1_Missense_Mutation_p.L62R|EGFR_ENST00000454757.2_Missense_Mutation_p.L9R|EGFR_ENST00000420316.2_Missense_Mutation_p.L62R	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	62		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L62R(3)	NA	NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GAGGTGGTCCTTGGGAATTTG	0.408		8	"""A, O, Mis"""	NA	"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	3	Substitution - Missense(3)	lung(2)|central_nervous_system(1)	NA	NA	NA	NA	NA				NA		175	167	170	NA	NA	NA	NA	7	NA	NA		NA						NA			NA				55210075		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	T	19.51	3.842145	0.71488	.	.	ENSG00000146648	ENST00000455089;ENST00000342916;ENST00000344576;ENST00000420316;ENST00000275493;ENST00000442591;ENST00000450046;ENST00000454757	T;T;T;T;T;T;T;T	0.79454	-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27;-1.27	6.05	4.9	0.64082	EGF receptor, L domain (1);	0.059356	0.64402	D	0.000001	D	0.87857	0.6283	M	0.86028	2.79	0.54753	D	0.999982	P;P;D;D;D	0.89917	0.882;0.795;1.0;0.991;0.992	P;P;D;P;P	0.74674	0.626;0.553;0.984;0.825;0.814	D	0.88586	0.3140	10	0.72032	D	0.01	.	11.1407	0.48400	0.0:0.0723:0.0:0.9277	.	62;62;62;62;62	Q504U8;P00533;P00533-3;P00533-4;P00533-2	.;EGFR_HUMAN;.;.;.	R	62;62;62;62;62;62;9;9	ENSP00000415559:L62R;ENSP00000342376:L62R;ENSP00000345973:L62R;ENSP00000413843:L62R;ENSP00000275493:L62R;ENSP00000410031:L62R;ENSP00000413354:L9R;ENSP00000395243:L9R	ENSP00000275493:L62R	L	+	2	0	EGFR	55177569	1.000000	0.71417	0.981000	0.43875	0.771000	0.43674	5.950000	0.70265	1.114000	0.41781	-0.263000	0.10527	CTT	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	57.955901	KEEP		+	84.403719	0.152838	35	194	---	---	---	---	1	0.7804049	11	7	0	221	37	207	0	221	2	1	1	93	535	0	590	37	207	0	221	2	TP
EGFR	1956	broad.mit.edu	37	7	55259515	55259515	+	Missense_Mutation	SNP	T	T	G	rs121434568		LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr7:55259515T>G	ENST00000275493.2	+	21	2750	c.2573T>G	c.(2572-2574)cTg>cGg	p.L858R	EGFR_ENST00000442591.1_Intron|EGFR_ENST00000455089.1_Missense_Mutation_p.L813R|EGFR_ENST00000454757.2_Missense_Mutation_p.L805R|EGFR-AS1_ENST00000442411.1_RNA	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	858	Protein kinase.	NA	L -> M (found in a lung cancer sample).|L -> R (found in a lung cancer sample; somatic mutation; constitutively activated enzyme with strongly increased kinase activity).		activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity	p.L858R(1489)|p.L858Q(1)|p.L858K(1)	NA	NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	GATTTTGGGCTGGCCAAACTG	0.537	L858R(NCIH1975_LUNG)	8	"""A, O, Mis"""	NA	"""glioma, NSCLC"""	NSCLC	NA		Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA		yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	1491	Substitution - Missense(1491)	lung(1475)|upper_aerodigestive_tract(5)|thyroid(4)|large_intestine(2)|peritoneum(1)|stomach(1)|thymus(1)|breast(1)|ovary(1)	NA	NA	NA	NA	NA				NA		105	98	101	NA	NA	NA	NA	7	NA	NA		NA						NA			NA				55259515		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	T	25.1	4.601026	0.87055	.	.	ENSG00000146648	ENST00000455089;ENST00000395504;ENST00000275493;ENST00000454757	D;D;D	0.91351	-2.83;-2.83;-2.83	5.71	5.71	0.89125	Serine-threonine/tyrosine-protein kinase (1);Protein kinase-like domain (1);Tyrosine-protein kinase, catalytic domain (1);Protein kinase, catalytic domain (1);	0.137592	0.50627	D	0.000117	D	0.96340	0.8806	M	0.92555	3.32	0.58432	D	0.999999	D;D	0.89917	0.999;1.0	D;D	0.91635	0.956;0.999	D	0.97213	0.9872	10	0.87932	D	0	.	14.8112	0.69996	0.0:0.0:0.0:1.0	.	813;858	Q504U8;P00533	.;EGFR_HUMAN	R	813;728;858;805	ENSP00000415559:L813R;ENSP00000275493:L858R;ENSP00000395243:L805R	ENSP00000275493:L858R	L	+	2	0	EGFR	55227009	1.000000	0.71417	1.000000	0.80357	0.962000	0.63368	7.890000	0.87313	2.176000	0.68965	0.528000	0.53228	CTG	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	18.26979	KEEP		+	34.388144	0.121739	14	101	---	---	---	---	1	0.9777558	34	9	0	134	18	115	0	134	2	1	1	78	517	0	553	18	115	0	134	2	TP
DCAF4L2	138009	broad.mit.edu	37	8	88885731	88885731	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr8:88885731C>T	ENST00000319675.3	-	1	565	c.469G>A	c.(469-471)Gtg>Atg	p.V157M		NM_152418.3	NP_689631.1	Q8NA75	DC4L2_HUMAN	DDB1 and CUL4 associated factor 4-like 2	157		NA						p.V157M(1)	NA	breast(3)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(19)|liver(2)|lung(40)|ovary(1)|prostate(3)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(1)	83						GGGAGCAGCACGGCACAGCTT	0.552		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		99	92	94	NA	NA	NA	NA	8	NA	NA		NA						NA			NA				88885731		2203	4300	6503	SO:0001583	missense				HGNC:26657	NM_152418	Approved	uc003ydz.3	NA		ENST00000319675.3	37	CCDS6245.1	.	.	.	.	.	.	.	.	.	.	C	11.76	1.733880	0.30684	.	.	ENSG00000176566	ENST00000319675	T	0.71222	-0.55	1.39	-0.0308	0.13912	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0.119123	0.85682	D	0.000000	T	0.62478	0.2431	L	0.36672	1.1	0.09310	N	0.999991	D	0.61080	0.989	P	0.53006	0.715	T	0.56300	-0.8002	10	0.62326	D	0.03	.	3.2853	0.06930	0.0:0.3119:0.0:0.6881	.	157	Q8NA75	DC4L2_HUMAN	M	157	ENSP00000316496:V157M	ENSP00000316496:V157M	V	-	1	0	DCAF4L2	88954847	1.000000	0.71417	0.003000	0.11579	0.002000	0.02628	1.772000	0.38552	-0.232000	0.09811	-0.373000	0.07131	GTG	DCAF4L2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000375302.1	-9.847468	KEEP		-	13.574074	0.060345	7	109	---	---	---	---	0	0	0	0	0	129	8	116	0	129	2	1	0.999998	44	495	0	583	8	116	0	129	2	TP
CHD9	80205	broad.mit.edu	37	16	53326814	53326814	+	Missense_Mutation	SNP	G	G	A			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr16:53326814G>A	ENST00000566029.1	+	29	5569	c.5360G>A	c.(5359-5361)cGt>cAt	p.R1787H	CHD9_ENST00000564845.1_Missense_Mutation_p.R1787H|CHD9_ENST00000447540.1_Missense_Mutation_p.R1787H|CHD9_ENST00000398510.3_Missense_Mutation_p.R1787H			Q3L8U1	CHD9_HUMAN	chromodomain helicase DNA binding protein 9	1787		NA			cellular lipid metabolic process|chromatin modification|regulation of transcription, DNA-dependent|transcription, DNA-dependent	cytoplasm|nucleoplasm	ATP binding|DNA binding|helicase activity|protein binding	p.R1787H(1)	NA	NS(1)|breast(4)|central_nervous_system(1)|endometrium(5)|kidney(6)|large_intestine(21)|lung(32)|ovary(2)|prostate(2)|skin(2)|stomach(1)|urinary_tract(1)	78		all_cancers(37;0.0212)				CGTTTGAGGCGTCTCATCACT	0.388		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA	G	HIS/ARG	5,3827	NA	1,3,1912	120	116	117	NA	5360	5.3	1	16	NA	117	2,8262	NA	0,2,4130	no	missense	CHD9	NM_025134.4	29	1,5,6042	AA,AG,GG	NA	0.0242,0.1305,0.0579	probably-damaging	1787/2882	53326814	7,12089	1916	4132	6048	SO:0001583	missense				HGNC:25701	NM_025134	Approved	uc002egy.3	NA	B2RTU2|B9ZVQ0|O15025|Q1WF12|Q6DTK9|Q9H9V7|Q9UHM2	ENST00000566029.1	37	CCDS45485.1	.	.	.	.	.	.	.	.	.	.	G	34	5.340537	0.95783	0.001305	2.42E-4	ENSG00000177200	ENST00000447540;ENST00000398510;ENST00000450543	D;D	0.91740	-2.9;-2.9	5.35	5.35	0.76521	.	0.000000	0.56097	D	0.000023	D	0.96694	0.8921	M	0.87971	2.92	0.80722	D	1	D;D;D;D	0.89917	1.0;1.0;0.999;0.999	D;D;D;D	0.97110	0.994;1.0;0.987;0.994	D	0.97217	0.9875	10	0.87932	D	0	-11.1255	19.0531	0.93053	0.0:0.0:1.0:0.0	.	155;1787;1787;1787	C9JR69;Q3L8U1-3;Q3L8U1;Q3L8U1-2	.;.;CHD9_HUMAN;.	H	1787;1787;155	ENSP00000396345:R1787H;ENSP00000381522:R1787H	ENSP00000381522:R1787H	R	+	2	0	CHD9	51884315	1.000000	0.71417	1.000000	0.80357	0.992000	0.81027	9.322000	0.96357	2.500000	0.84329	0.591000	0.81541	CGT	CHD9-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000422338.1	45.344074	KEEP		+	64.023729	0.156627	26	140	---	---	---	---	1	0.5926076	5	8	0	158	27	158	0	158	2	0	0	0	0	0	0	27	158	0	158	2	TP
POLR2A	5430	broad.mit.edu	37	17	7416688	7416688	+	Missense_Mutation	SNP	C	C	T			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr17:7416688C>T	ENST00000322644.6	+	29	5504	c.5105C>T	c.(5104-5106)aCa>aTa	p.T1702I		NM_000937.4	NP_000928.1	P24928	RPB1_HUMAN	polymerase (RNA) II (DNA directed) polypeptide A, 220kDa	1702	52 X 7 AA approximate tandem repeats of Y-[ST]-P-[STQ]-[ST]-P-[SRTEVKGN].	NA			mRNA capping|nuclear mRNA splicing, via spliceosome|positive regulation of viral transcription|protein phosphorylation|regulation of transcription, DNA-dependent|transcription elongation from RNA polymerase II promoter|transcription initiation from RNA polymerase II promoter|transcription-coupled nucleotide-excision repair|viral reproduction	DNA-directed RNA polymerase II, core complex	DNA binding|DNA-directed RNA polymerase activity|metal ion binding|RNA-directed RNA polymerase activity|ubiquitin protein ligase binding	p.T1702I(1)	NA	breast(3)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(6)|large_intestine(8)|lung(17)|pancreas(1)|prostate(1)|skin(5)|upper_aerodigestive_tract(1)	50		Prostate(122;0.173)				tactcaccgacatctcccagc	0.587		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		382	318	339	NA	NA	NA	NA	17	NA	NA		NA						NA			NA				7416688		2202	4296	6498	SO:0001583	missense			ENSG00000181222	HGNC:9187	NM_000937	Approved	uc002ghf.4	NA	A6NN93|B9EH88	ENST00000322644.6	37	CCDS32548.1	.	.	.	.	.	.	.	.	.	.	C	12.58	1.980526	0.34942	.	.	ENSG00000181222	ENST00000535204;ENST00000545644;ENST00000322644	T	0.73363	-0.74	3.4	3.4	0.38934	.	0.325754	0.12477	U	0.465478	D	0.86041	0.5838	M	0.89904	3.07	0.80722	D	1	P	0.48407	0.91	P	0.56648	0.803	D	0.86515	0.1812	10	0.44086	T	0.13	-9.5874	14.1359	0.65287	0.0:1.0:0.0:0.0	.	1702	P24928	RPB1_HUMAN	I	1658;601;1702	ENSP00000314949:T1702I	ENSP00000314949:T1702I	T	+	2	0	SLC35G6	7357412	0.991000	0.36638	0.789000	0.31954	0.411000	0.31082	5.131000	0.64751	1.904000	0.55121	0.456000	0.33151	ACA	POLR2A-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000437967.1	10.563515	KEEP		+	12.453337	0.208333	5	19	---	---	---	---	1	0.9999183	26	114	0	45	5	22	0	45	2	0	0	0	0	0	0	5	22	0	45	2	TP
BCAS3	54828	broad.mit.edu	37	17	59024579	59024579	+	Splice_Site	SNP	G	G	T			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr17:59024579G>T	ENST00000589222.1	+	14	1155		c.e14-1		BCAS3_ENST00000407086.3_Splice_Site|BCAS3_ENST00000585744.1_Splice_Site|BCAS3_ENST00000408905.3_Splice_Site|BCAS3_ENST00000390652.5_Splice_Site|BCAS3_ENST00000588874.1_Splice_Site|BCAS3_ENST00000588462.1_Splice_Site			Q9H6U6	BCAS3_HUMAN	breast carcinoma amplified sequence 3	NA		NA				nucleus		p.?(1)	NA	NS(1)|central_nervous_system(2)|haematopoietic_and_lymphoid_tissue(2)|kidney(2)|large_intestine(5)|lung(24)|ovary(3)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	44			BRCA - Breast invasive adenocarcinoma(1;3.11e-12)|Epithelial(12;8.2e-07)|all cancers(12;5.33e-06)			TTGTCTTCCAGGAATGCTTCT	0.353		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Unknown(1)	lung(1)	NA	NA	NA	NA	NA				NA		175	157	162	NA	NA	NA	NA	17	NA	NA		NA						NA			NA				59024579		1860	4105	5965	SO:0001630	splice_region_variant			ENSG00000141376	HGNC:14347	NM_017679	Approved	uc002iyv.4	NA	Q17RM0|Q6KF21|Q8IXI6|Q8NDR8|Q8TDL9|Q8TDM1|Q8WY55|Q9BVF0|Q9H957|Q9H9Y9|Q9NXP4	ENST00000589222.1	37		.	.	.	.	.	.	.	.	.	.	G	26.2	4.713930	0.89112	.	.	ENSG00000141376	ENST00000390652;ENST00000407086;ENST00000405070;ENST00000408905;ENST00000360207;ENST00000405217	.	.	.	5.59	5.59	0.84812	.	.	.	.	.	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	19.9542	0.97213	0.0:0.0:1.0:0.0	.	.	.	.	.	-1	.	.	.	+	.	.	BCAS3	56379361	1.000000	0.71417	1.000000	0.80357	0.988000	0.76386	9.412000	0.97347	2.788000	0.95919	0.585000	0.79938	.	BCAS3-004	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000449571.1	3.781448	KEEP	Intron	+	50.940465	0.087591	24	250	---	---	---	---	1	0.941091	9	38	0	287	29	274	0	287	2	0	0	0	0	0	0	29	274	0	287	2	TP
HIRA	7290	broad.mit.edu	37	22	19398295	19398295	+	Missense_Mutation	SNP	G	G	A			LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	LUAD-TCGA-38-4627-Tumor-SM-1U1IZ	LUAD-TCGA-38-4627-Normal-SM-1U1JB	g.chr22:19398295G>A	ENST00000263208.5	-	2	300	c.44C>T	c.(43-45)cCg>cTg	p.P15L	HIRA_ENST00000546308.1_5'UTR|HIRA_ENST00000541063.1_5'UTR|HIRA_ENST00000340170.4_Missense_Mutation_p.P15L|HIRA_ENST00000464189.1_5'UTR	NM_003325.3	NP_003316.3	P54198	HIRA_HUMAN	histone cell cycle regulator	15		NA			chromatin modification|regulation of transcription from RNA polymerase II promoter	PML body	chromatin binding|protein binding|sequence-specific DNA binding transcription factor activity|transcription corepressor activity	p.P15L(1)	NA	autonomic_ganglia(1)|breast(3)|central_nervous_system(1)|cervix(1)|endometrium(7)|haematopoietic_and_lymphoid_tissue(1)|kidney(1)|large_intestine(4)|lung(14)|ovary(2)|prostate(1)|skin(1)	37	Colorectal(54;0.0993)					TGAAAAAATCGGCTTGCCTGG	0.378		NA		NA			NA				NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA						NA		NA		NA		1	Substitution - Missense(1)	lung(1)	NA	NA	NA	NA	NA				NA		173	181	179	NA	NA	NA	NA	22	NA	NA		NA						NA			NA				19398295		2203	4300	6503	SO:0001583	missense			ENSG00000100084	HGNC:4916	NM_003325	Approved	uc002zpf.1	NA	Q05BU9|Q8IXN2	ENST00000263208.5	37	CCDS13759.1	.	.	.	.	.	.	.	.	.	.	G	28.2	4.902279	0.92035	.	.	ENSG00000100084	ENST00000340170;ENST00000263208	D;T	0.81659	-1.52;-0.26	4.49	4.49	0.54785	WD40/YVTN repeat-like-containing domain (1);WD40 repeat-like-containing domain (1);	0.000000	0.85682	D	0.000000	D	0.90830	0.7120	M	0.87328	2.875	0.80722	D	1	D;D	0.89917	1.0;1.0	D;D	0.79108	0.992;0.99	D	0.92499	0.6007	10	0.72032	D	0.01	-10.3749	17.7299	0.88374	0.0:0.0:1.0:0.0	.	15;15	P54198-2;P54198	.;HIRA_HUMAN	L	15	ENSP00000345350:P15L;ENSP00000263208:P15L	ENSP00000263208:P15L	P	-	2	0	HIRA	17778295	1.000000	0.71417	1.000000	0.80357	0.977000	0.68977	8.793000	0.91862	2.485000	0.83878	0.655000	0.94253	CCG	HIRA-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000316488.2	27.309519	KEEP		-	78.349868	0.103976	34	293	---	---	---	---	1	0.8454133	2	27	0	355	40	319	0	355	2	0	0	0	0	0	0	40	319	0	355	2	TP
